Pages

Monday, July 14, 2014

FDA Office of Drug Evaluation III Approves Salix's Request that the ...

... Injection Compared to Patients Using Other Comparator Treatments for Opioid-induced Constipation RALEIGH, N.C. & TARRYTOWN, N.Y.--( BUSINESS WIRE )--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today ...

http://ift.tt/1qzBEJd

No comments:

Post a Comment